↓ Skip to main content

Challenges and future prospects of antibiotic therapy: from peptides to phages utilization

Overview of attention for article published in Frontiers in Pharmacology, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
268 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
Published in
Frontiers in Pharmacology, May 2014
DOI 10.3389/fphar.2014.00105
Pubmed ID
Authors

Santi M. Mandal, Anupam Roy, Ananta K. Ghosh, Tapas K. Hazra, Amit Basak, Octavio L. Franco

Abstract

Bacterial infections are raising serious concern across the globe. The effectiveness of conventional antibiotics is decreasing due to global emergence of multi-drug-resistant (MDR) bacterial pathogens. This process seems to be primarily caused by an indiscriminate and inappropriate use of antibiotics in non-infected patients and in the food industry. New classes of antibiotics with different actions against MDR pathogens need to be developed urgently. In this context, this review focuses on several ways and future directions to search for the next generation of safe and effective antibiotics compounds including antimicrobial peptides, phage therapy, phytochemicals, metalloantibiotics, lipopolysaccharide, and efflux pump inhibitors to control the infections caused by MDR pathogens.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 268 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Sweden 1 <1%
Unknown 266 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 46 17%
Student > Bachelor 45 17%
Student > Master 30 11%
Researcher 26 10%
Student > Postgraduate 12 4%
Other 41 15%
Unknown 68 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 46 17%
Agricultural and Biological Sciences 46 17%
Medicine and Dentistry 20 7%
Immunology and Microbiology 17 6%
Chemistry 17 6%
Other 42 16%
Unknown 80 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2016.
All research outputs
#14,780,519
of 22,755,127 outputs
Outputs from Frontiers in Pharmacology
#5,150
of 16,008 outputs
Outputs of similar age
#127,553
of 226,936 outputs
Outputs of similar age from Frontiers in Pharmacology
#34
of 82 outputs
Altmetric has tracked 22,755,127 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,008 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,936 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.